The Researcher is In

[ Contents | Search | Next | Previous | Up ]


Re: drug studies for stuttering

From: Nathan Lavid, M.D.
Date: 09 Oct 2005
Time: 21:21:58 -0500
Remote Name: 71.107.205.117

Comments

Hello Patti, I’m glad to read of your interest, though sorry to read of these experiences. It’s impossible to evaluate medication recommendations from hearsay, especially when it pertains to mental illness as the stigma of mental illness has an effect on candid public discussion. Wellbutrin is commonly used for depression and at times as a second-line agent for AD/HD and a depressive episode of bipolar disorder. Possibly, the use Wellbutrin was deemed to be effective for the patient’s mood disorder and supersede the risks on fluency. Or, like you mention, the physician did not know of the stuttering or the effects of the medication on speech. If the later, a simple solution would be to write or call the prescribing physician and inform him or her of the side effects. Some medical practices only allow a short time for visits, and time constraints may effect physician-patient communication. In my practice, I dictate an initial letter to the referring clinician and make follow-up phone calls if needed. Also, I’d be pleased to answer any questions you might have after this conference is over. Just send me an email nlavid@nathanlavidmd.com or call 562-624-2828.


Last changed: 10/31/05